Lithium Ion

Lithium Ion

SCHEMBL18247696

CCn1c(-c2nc3cc(C(=O)[O-])cnc3n2C)cc2ccccc21.[Li+]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PADI4 Q9UM07 11/20 0.49
TRPM8 Q7Z2W7 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
PTGER4 P35408 3/20 0.39
MAPK1 P28482 1/20 0.39
GAA P10253 2/20 0.38
HPGD P15428 1/20 0.38
PDE4A P27815 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL30325457 1.00 PADI4 (0.49) PADI4TRPM8CA12CA9PTGER4
SCHEMBL25145034 0.90 PADI4 (0.51) PADI4CA12CA9PTGER4MAPK1
SCHEMBL18247513 0.90 PADI4 (0.51) PADI4CA12CA9PTGER4MAPK1
Lithium SCHEMBL18247699 0.89 PADI4 (0.50) PADI4CA12CA9PTGER4MAPK1
SCHEMBL18247694 0.89 PADI4 (0.50) PADI4CA12CA9PTGER4MAPK1
SCHEMBL18247704 0.87 PADI4 (0.49) PADI4CA12CA9PTGER4PDE4A
SCHEMBL25145307 0.87 PADI4 (0.49) PADI4CA12CA9PTGER4MAPK1
SCHEMBL25145174 0.81 PTGER4 (0.51) PADI4CA12CA9PTGER4MAPK1
SCHEMBL18247673 0.79 PADI4 (0.78) PADI4
SCHEMBL18247674 0.79 PADI4 (0.78) PADI4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3298003-A1 BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS GlaxoSmithKline Intellectual Property Development Limited (GB) 2018-03-28 EP disclosed
WO-2016185279-A1 BENZOIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2016-11-24 WO disclosed